MUSC to leverage Glytec software to enhance clinical outcomes, quality, safety
New collaboration to have broad impact on diabetes, insulin management for leading academic health system in
With over 37 million Americans currently diagnosed with either Type 1 or Type 2 diabetes, and many more at risk, Glytec's technology marks a major advancement in managing this widespread condition. More than one-third of hospitalized patients require insulin therapy, underscoring the need for effective software to manage workflows and patient care – now further emphasized by new Centers for Medicare and Medicaid Services (CMS) hospital glycemia reporting mandates.
MUSC's leadership team and Information Technology experts conducted a comprehensive evaluation of available diabetes and insulin management solutions and selected Glytec for its ability to integrate with the health system's existing electronic medical record (EMR) system, EPIC. Glytec's platform will provide advanced clinical decision support, streamline insulin therapy and reduce variability in glycemic management, ultimately helping clinicians to make more informed decisions and ultimately improve patient outcomes.
"Our collaboration with Glytec marks a significant milestone in our ongoing efforts to enhance diabetes care across MUSC," said
With a mission to deliver high-quality care and innovative treatment solutions, MUSC is dedicated to advancing diabetes management and addressing the complexities of glycemic control. This relationship will enable MUSC Health's hospitals to utilize Glytec's FDA-cleared software to ensure that all clinical settings across the system are fully prepared to meet the new CMS requirements.
"We are excited to collaborate with MUSC and to support their commitment to innovation in diabetes care," said
About Glytec
Glytec's industry-leading SaaS platform, trusted by over 350 hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing hospital length of stay, and optimizing clinical workflows. The first-ever FDA-cleared cloud-based insulin management software integrates seamlessly with EMRs, providing advanced clinical decision support, workflow alerts, patient monitoring, and AI-driven analytics. Supported by over 100 patents and peer-reviewed publications, Glytec is dedicated to improving diabetes care from hospital to home. For more information, visit www.glytec.com or follow Glytec on LinkedIn.
About MUSC
Founded in 1824 in
As the health care system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest-quality and safest patient care while educating and training generations of outstanding health care providers and leaders to serve the people of
MUSC has a total enterprise annual operating budget of
Media Contact:
Public Relations
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/musc-to-leverage-glytec-software-to-enhance-clinical-outcomes-quality-safety-302459588.html
SOURCE Glytec, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
- BNP PARIBAS GROUP: SUDAN LITIGATION STATEMENT FROM BNP PARIBAS
- Bio Ionic Partners with Ulta Beauty on Limited Edition Jade Dream Collection
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share